MedPath

Efficacy Study of Zeller Entspannung Film Coated Tablets on Acute Stress

Phase 4
Completed
Conditions
The Primary Condition Studied for This Trial is Acute Stress
Interventions
Other: No Treatment
Drug: Placebo
Registration Number
NCT02189239
Lead Sponsor
Max Zeller Soehne AG
Brief Summary

The objective of the STRESS trial is to investigate in a mode of action setting the effect of Zeller Entspannung film coated tablets on saliva cortisol response versus Placebo after acute stress in healthy male volunteers. In addition, data on safety and tolerability of Zeller Entspannung will be obtained.

A third arm including no treatment is tested as well. Approximately 72 healthy volunteers will be included into this randomized, double blind study. Study duration will be 7 days, study medication intake will be over 4 days: participants will take the medication one tablet three times a day (morning, midday, evening) the first 3 days, whereas on day 4 only two tablets will be taken (morning and midday).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
72
Inclusion Criteria
  • Age:18 - 45 years
  • Written informed consent
  • Male gender
Exclusion Criteria
  • Any acute or chronic somatic or psychiatric disorder
  • Smoking
  • Any clinically relevant hepatic disorder
  • Any clinically relevant renal disorder
  • Any clinically relevant cardiac disorder
  • Any clinically relevant respiratory disease (e.g. Asthma)
  • Diabetes mellitus
  • Any abnormal lab values suggesting diseases from exclusion criteria
  • Known allergies to trial medication and excipients
  • Alcohol or other drug abuse (e.g. cannabis)
  • Concomitant participation in another clinical trial or <4 weeks ago
  • Participation in any psychotherapy
  • Already participated in a TSST

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
No TreatmentNo TreatmentNo medication intake.
Placebo tabletsPlaceboPlacebo medication is identical in presentation, color and shape, 3x1 tablet per day for the first three days (morning, midday, evening), at day four 2x1 tablet (morning, midday) during meals with a glass of water.
Zeller Entspannung film coated tabletsZeller Entspannung film coated tabletRelaxing film coated tablets, 570 mg (Zeller Entspannung Filmtabletten), 3x1 tablet per day for the first three days (morning, midday, evening), at day four 2x1 tablet (morning, midday) preferably during meals with a glass of water.
Primary Outcome Measures
NameTimeMethod
The primary objective is to demonstrate in healthy male volunteers that Zeller Entspannung reduces overall saliva cortisol level (AUCg) after acute stress compared with a placebo.4 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Phase I Research Unit, University Hospital Basel

🇨🇭

Basel, Switzerland

© Copyright 2025. All Rights Reserved by MedPath